Genetic Engineering? FDA Looks at Facts on Three-Parent Embryos

In public hearings that began last week, scientists presented research to outside advisors to the U.S. Food and Drug Administration and the agency will decide if clinical trials can start. The big question is whether trials would be safe for women and any children born via the procedure. Trials done with animals may not have provided enough data for a clear decision. The…

X